Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 807-130-4 | CAS number: 53716-82-8
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
In the key local lymph node assay, conducted according to OECD Test Guideline 429 and in compliance with GLP, the test substance, Cyrene™, was concluded to be not sensitising to skin based on Stimulation Index (SI) values of <3 when tested at 5, 10 or 25% concentration (Harlan Cytotest Cell Research GmbH, 2014c).
Key value for chemical safety assessment
Skin sensitisation
Link to relevant study records
- Endpoint:
- skin sensitisation: in vivo (LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 30 Apr - 02 Jun 2014
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 429 (Skin Sensitisation: Local Lymph Node Assay)
- Version / remarks:
- adopted 22 July 2010
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.42 (Skin Sensitisation: Local Lymph Node Assay)
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Remarks:
- Hess. Ministerium für Umwelt, Energie, Landwirtschaft und Verbraucherschutz, Wiesbaden, Germany
- Type of study:
- mouse local lymph node assay (LLNA)
- Species:
- mouse
- Strain:
- other: CBA/CaOlaHsd
- Sex:
- female
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Source: Harlan Laboratories B. B., Horst, Netherlands
- Age at study initiation: 1st pre-test: 8 - 9 weeks; 2nd pre-test: 10 - 11 weeks; main study: 10 - 11 weeks
- Weight at study initiation: 1st pre-test: 19.8 - 21.3 g; 2nd pre-test: 20.5 - 20.1 g; main study 19.1. - 22.5 g
- Housing: group of 2 (pre-studies)/ 4 (main study) animals per cage in Makrolon Type II (pre-test)/ III (main study), with wire mesh top, granulated soft wood bedding
- Diet: 2018C Teklad Global 18% protein rodent diet (certified), ad libitum
- Water: tap water, ad libitum
- Acclimation period: at least 5 days prior start of dosing
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22 ± 2
- Humidity (%): 45 - 65, except for several hours on four non consecutive days (28 - 65%)
- Photoperiod (hrs dark / hrs light): 12/12 - Vehicle:
- acetone/olive oil (4:1 v/v)
- Concentration:
- 5, 10 and 25%
- No. of animals per dose:
- 4
- Details on study design:
- RANGE FINDING TESTS:The first pre-test was performed with 50 and 100% test item concentration. Animals treated with 50% test item concentration showed an erythema of the ear skin (Score 1) on day 1 to 4. Animals treated with 100% test item concentration showed an erythema of the ear skin (Score 1) between day 1 and 5. The ear thickness for animals treated with 50% test item concentration increased by 27.2% which is considered as an excessive ear irritation because the increase in ear weight is ≥ 25%. The second pre-test was performed with 10 and 25% test item concentration. Animals treated with 10% test item concentration showed an erythema of the ear skin (Score 1) on day 3. Animals treated with 25% test item concentration showed an erythema of the ear skin (Score 1) between day 2 and 3. Due to these results the test item concentration in the main study was assayed at 5, 10 and 25%, where the highest concentration tested was the highest concentration level that could be achieved whilst avoiding systemic toxicity and excessive local skin irritation.
MAIN STUDYANIMAL ASSIGNMENT AND TREATMENT
- Name of test method: 3H-methyl thymidine incorporation determined by β-scintillation
- Criteria used to consider a positive response:
A) the exposure to at least one concentration of the test item resulted in an incorporation of 3HTdR at least 3-fold or greater than that recorded in control mice, as indicated by the Stimulation Index,
B) the data are compatible with a conventional dose response, although allowance must be made (especially at high topical concentrations) for either local toxicity or immunological suppression.
TREATMENT PREPARATION AND ADMINISTRATION: 25 µL of the test item was spread over the entire dorsal surface of each ear of each mouse once daily for three consecutive days. Local irritation reactions were assessed. On day 6, 250 µL of phosphate-buffered saline containing 20.4 µCi of 3H-methyl thymidine were injected into each test and control mouse via the tail vein. Approximately 5 h later the draining lymph nodes were excised and pooled for each treatment group. A single cell suspension of lymph node cells of pooled lymph nodes was prepared by gentle mechanical disaggregation through stainless steel gauze (200 µm mesh size). Macromolecules were precipitated with 5% trichloroacetic acid at 4 °C for at least 18 h. - Positive control substance(s):
- hexyl cinnamic aldehyde (CAS No 101-86-0)
- Positive control results:
- The positive control substance α-hexyl cinnamic aldehyde with a concentration of 25% in acetone/olive oil (4 + 1; v/v) induced a positive reaction with a stimulation index of 6.79.
- Key result
- Parameter:
- SI
- Value:
- 0.49
- Test group / Remarks:
- 5% test substance in acetone/olive oil (4 + 1; v/v)
- Key result
- Parameter:
- SI
- Value:
- 0.76
- Test group / Remarks:
- 10% test substance in acetone/olive oil (4 + 1; v/v)
- Key result
- Parameter:
- SI
- Value:
- 1.03
- Test group / Remarks:
- 25%test substance in acetone/olive oil (4 + 1; v/v)
- Key result
- Parameter:
- other: disintegrations per minute (DPM)
- Value:
- 1 027.5
- Test group / Remarks:
- Negative control group
- Key result
- Parameter:
- other: disintegrations per minute (DPM)
- Value:
- 504.1
- Test group / Remarks:
- 5% test substance in acetone/olive oil (4 + 1; v/v)
- Key result
- Parameter:
- other: disintegrations per minute (DPM)
- Value:
- 775.9
- Test group / Remarks:
- 10% test substance in acetone/olive oil (4 + 1; v/v)
- Key result
- Parameter:
- other: disintegrations per minute (DPM)
- Value:
- 1 063
- Test group / Remarks:
- 25% test substance in acetone/olive oil (4 + 1; v/v)
- Key result
- Parameter:
- SI
- Value:
- 6.79
- Test group / Remarks:
- Positive control 25% α-hexylcinnamaldehyde in acetone/olive oil (4+1; v/v)
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- In the key local lymph node assay, conducted according to OECD Test Guideline 429 and in compliance with GLP, the test substance, Cyrene™, was concluded to be not sensitising to skin based on Stimulation Index (SI) values of <3 when tested at 5, 10 or 25% concentration.
Reference
No signs of systemic toxicity were observed during the study period. Animals treated with 25% test item concentration showed an erythema of the ear skin with a score of 1 on day 3 and 4, whereas animals treated with 5 and 10% test item concentration did not show any signs of local skin irritation.
The body weights of the animals were recorded prior the first application and before treatment with 3H-methyl-thymidine. The weights were within the range commonly recorded for animals of this strain and age.
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (not sensitising)
- Additional information:
In the key local lymph node assay, conducted according to OECD Test Guideline 429 and in compliance with GLP, the test substance, Cyrene™, was reported to be not sensitising to skin based on Stimulation Index (SI) values of <3 at all test concentrations. No signs of systemic toxicity were observed during the study period (Harlan Cytotest Cell Research GmbH, 2014c).
At induction, 25 µL of the test item were applied onto the entire dorsal surface of each ear of each mouse once daily for three consecutive days. Local irritation reactions were assessed. At challenge, on day 6, 250 µL of phosphate-buffered saline containing 20.4 µCi of 3H-methyl thymidine were injected into each test and control mouse via the tail vein. Approximately 5 hours later the draining lymph nodes were excised and pooled for each treatment group. A single cell suspension of lymph node cells of pooled lymph nodes was prepared by gentle mechanical disaggregation through stainless steel gauze (200 µm mesh size). Macromolecules were precipitated with 5% trichloroacetic acid at 4°C for at least 18 hours.
No signs of systemic toxicity were observed during the study period. Animals treated with 25% test item concentration showed an erythema of the ear skin with a score of 1 on day 3 and 4, whereas animals treated with 5 and 10% test item concentration did not show any signs of local skin irritation. The body weights of the animals were recorded prior the first application and before treatment with 3H-methyl-thymidine. The weights were within the range commonly recorded for animals of this strain and age. The stimulation indices (SI) of 0.49, 0.76 and 1.03 were determined with the test item concentrations of 5, 10 and 25% in acetone/olive oil (4 + 1; v/v). The EC3 value could not be calculated, since none of the tested concentrations induced a SI greater than the threshold value of 3.
Respiratory sensitisation
Endpoint conclusion
- Endpoint conclusion:
- no study available
Justification for classification or non-classification
Based on the available data for Cyrene™, no classification for skin sensitisation is required according to Regulation (EC) No 1272/2008.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.